Company Filing History:
1 out of 14 
1 out of 1,290 
Years Active: 2024
Title: Javier De Ceballos Cerrajeria: Innovator in Glucose Transport Inhibition
Introduction
Javier De Ceballos Cerrajeria is a notable inventor based in Vaud, Switzerland. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit glucose transporters.
Latest Patents
Javier holds a patent for his invention titled "Inhibitors of glucose transporters (GLUTs)." This patent relates to 2,6-methanobenzo[g][1]oxacin-4-one compounds and their analogs, which serve as selective inhibitors of glucose transporters 1 and 3 (GLUTs 1 and 3). The invention outlines methods for preparing these compounds and their use as pharmaceutically active agents. These agents are particularly relevant for the prophylaxis and treatment of various metabolic, immunological, and autoimmune diseases, as well as inflammation, graft versus host disease, cancer, and its metastasis. Additionally, the patent includes pharmaceutical compositions comprising at least one of these compounds.
Career Highlights
Throughout his career, Javier has worked with esteemed organizations such as Lead Discovery Center GmbH and the Max Planck Society for the Advancement of Science. His work in these institutions has allowed him to further his research and development in the pharmaceutical field.
Collaborations
Javier has collaborated with notable colleagues, including Herbert Waldmann and Gunther Zischinsky. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Javier De Ceballos Cerrajeria is a distinguished inventor whose work in glucose transporter inhibition has the potential to impact the treatment of various diseases. His innovative approach and collaborations highlight his commitment to advancing pharmaceutical science.